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Abstract
Objective. The shielding guidance in the UK for the clinically extremely vulnerable (CEV) commenced
on 23 March 2020 in response to the coronavirus disease 2019 (COVID-19) pandemic. The purpose of
this study was to explore the impact of the pandemic and shielding on patients with lupus and related
systemic autoimmune rheumatic diseases (SARDs).
Methods. This was a mixed-methods cohort study (n¼ 111) including pre-lockdown baseline surveys
(March 2020), follow-up surveys (June 2020) and in-depth interviews during July 2020 (n¼ 25).
Results. Most participants had a high level of anxiety regarding their mortality risk from COVID-19
and supported the concept of shielding. Shielding allocations and communications were perceived as
inconsistently applied and delivered. More than half of those not classified as CEV reported feeling
abandoned, at increased risk and with no support. Shielding communications increased feelings of be-
ing ‘cared about’, but also increased fear, and the ‘vulnerable’ labelling was perceived by some to
damage social and self-identity. More than 80% of those classified as CEV stated that the classifica-
tion and subsequent communications had changed their social-mixing behaviour. Despite many nega-
tive impacts of COVID-19 and shielding/lockdown being identified, including isolation, fear and reduced
medical care, the quantitative data during the pandemic showed increases in most measures of well-
being (which was low at both time points) from pre-lockdown, including reductions in the impact of fa-
tigue and pain (P-values< 0.001).
Conclusion. Shielding classifications and communications were, in general, viewed positively, al-
though they were perceived as inconsistently delivered and anxiety-provoking by some participants.
More frequent positively framed communication and wellbeing support could benefit all SARD patients.
Slower-paced lockdown lifestyles might confer health/wellbeing benefits for some people with chronic
diseases.
Key words: COVID-19, shielding, rheumatology, systemic lupus erythematosus, systemic autoimmune rheu-
matic disease, lupus, quality of life, patient views, patient behaviour, mixed methods
Introduction
At its outset, coronavirus disease 2019 (COVID-19) was
anticipated to have a significant impact on the wellbeing
of patients with lupus and related systemic autoimmune
rheumatic diseases (SARDs). These patients have com-
plex multi-system disease, often with unpredictable
flares and frequent use of immunosuppression, the main
criteria for risk assessment and shielding classification
in this group [1].
The first UK ‘lockdown’, which commenced on 23
March 2020, was accompanied by more stringent
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government guidance to those identified as being clini-
cally extremely vulnerable (CEV), initially by National
Health Service (NHS) digital [2] and subsequently by hospi-
tal clinicians and general practitioners (GPs) for further eligi-
ble patients. The identification process and shielding
guidance/timescales differed for each UK devolved nation.
The CEV were advised to ‘shield’, which included not leav-
ing homes/gardens (except for medical appointments) and
physically distancing from other household members [3].
As a group, lupus patients and those with related condi-
tions are likely to have been affected disproportionately by
the negative impact of shielding on mental health (MH) [4]
owing to approximately one-third meeting shielding criteria
[5].
In addition, the adverse impact of other aspects of
the pandemic on MH found in the UK population [6, 7]
could also have impacted patients with lupus and re-
lated diseases disproportionately, in part owing to some
of the identified risk factors also being associated with
SARDs, including: having a pre-existing physical or
mental health [8] condition and/or multimorbidity [6];
lower income and/or not having a job [9], with pre-
pandemic studies having found employment and income
disadvantage among lupus and SARD patients [10–12];
and reduced access during the pandemic to normal
chronic illness care [13–15]. Our previous COVID-19
study found that the majority of this cohort of partici-
pants reported that disruptions to their medical care had
adversely impacted their MH [14].
Although the published literature suggests the possi-
bility of multiple negative impacts of the pandemic on
SARD patients [4, 5, 13, 14], the aim of this study was
to explore in depth the nature and magnitude of the
negative impacts (within the limits of the sample), partic-
ularly in relationship to shielding.
Methods
Detailed methods, including the consolidated criteria for
reporting qualitative research (COREQ) checklist [16],
are provided in Supplementary Data S1, available at
Rheumatology Advances in Practice online.
Data collection
This mixed-methods study integrates findings from: (a)
quantitative and qualitative data from a cohort of partici-
pants [14] who completed both pre-lockdown baseline
(4–10 March 2020) and follow-up (10–21 June 2020)
online surveys; (b) a content and qualitative analysis of
COVID-19 posts on the LUPUS UK forum (March–
August 2020); and (c) in-depth interviews (July 2020).
The cohort was from a pre-existing longitudinal study
[14] focusing on MH/wellbeing, medical care and peer
support (pre-registered: ISRCTN-14966097). Informed
consent was obtained before surveys and interviews.
The online surveys were made available on the LUPUS
UK forum and Lupus support UK Facebook group for
study sign-up for any prospective participant meeting
the following inclusion criteria: a diagnosis of lupus/other
related SARD (as detailed on participants’ clinic letters);
18 years of age; and resident in the UK.
Ethical approval was obtained through the Cambridge
Psychology Research Committee (PRE.2019.099: ap-
proval for original peer-support trial; PRE.2020.089: ap-
proval for COVID-19 related changes to survey and
interviews; and PRE.2018.120: approval for analysis of
the LUPUS UK forum).
The primary outcome measure was the Warwick-
Edinburgh Mental Wellbeing Scale (WEMWS) [17], with the
follow-up survey adapted to include questions on the im-
pact of the pandemic and shielding. Survey responses
were analysed and used to inform purposive sampling
(non-random selection of interviewees to ensure a wide
range of socio-demographics and experiences/views).
Interviews explored participants’ experiences of the shield-
ing policy, communication, medical care, and perceived
impacts on MH and behaviour. Interviews were conducted
by M.S., predominantly by telephone. They lasted 1 hour
and were audio-recorded and transcribed verbatim.
Interviewing continued until thematic saturation [18] (no
novel findings from subsequent interviews) was reached.
Analysis
Integration of data sources occurred throughout, with
the qualitative components being analysed thematically
[19] to further explore and explain quantitative results.
Validity and reliability were enhanced by: M.S. coding all
data (using Nvivo12), R.H. double-coding 25% of tran-
scripts, E.L. and M.A.B. reviewing qualitative data and
independently generating proposed themes, confirming
that patients were in agreement with arising themes
(member checking) [20], triangulation of multiple data
sources and consideration of deviant cases [21].
Emerging themes were then agreed by the wider team,
including patient representatives. Quantitative data were
analysed using SPSS v.26 (IBM Corp., Armonk, NY).
Key messages
. The concept of shielding was supported by lupus/systemic autoimmune rheumatic disease patients and
engendered more socially avoidant behaviour.
. Inconsistently applied shielding allocation omitted many patients, generating feelings of abandonment and
endangerment.
. Multiple health/wellbeing measures improved unexpectedly during lockdown/shielding, probably from a slower-
paced lifestyle.
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Test diagnostics were examined, and all were satisfac-
tory. Student’s paired t tests were used for assessing
change over time for continuous outcomes, and v2 test
or Fisher’s exact test for categorical outcomes.
Results
Survey respondents (n¼ 111) and interviewees (n¼25)
encompassed a broad range of socio-demographic
characteristics, although all but two participants were
female (Table 1). Fifty-one per cent of survey partici-
pants reported being allocated to the shielding cate-
gory. Any percentages/statistics reported are from the
surveys.
Four key themes were identified: (a) impact of COVID-
19 on MH/wellbeing; (b) inconsistency in risk classification
and communication; (c) the impact of the risk classification
and shielding on multiple domains; and (d) lessons learnt
from lockdown lifestyle for SARD management.
Theme 1: impact of COVID-19 on MH/wellbeing
The primary outcome measure of wellbeing, using
changes in the total WEMBS (scale from 14 to 70, with
higher scores representing better wellbeing), showed a
small and non-statistically significant improvement
(P¼0.084) from pre-lockdown (38.6) to during-pandemic
(39.8) surveys, with no significant difference between
shielders and non-shielders.
TABLE 1 Participant characteristics (n¼111)
Characteristic Number








20–29 20 18 5 20
30–39 18 16 3 12
40–49 23 21 6 24
50–59 31 28 5 20
60–69 15 14 4 16
70þ 4 4 2 8
Diagnosis
SLE 87 78 15 60
UCTD 7 6 4 16
SSS 5 5 2 8
MCTD or overlap CTD 6 5 1 4
Cutaneous lupus 4 4 2 8
Probable or incomplete lupus 2 2 1 4
Employment
Employed full time 27 24 5 20
Employed part time 22 20 5 20
Self-employed 7 6 3 12
Not currently working owing to health 31 28 7 28
Retired 19 17 5 20
Other 5 5 0 0
Ethnicity
Asian 6 5 2 8
White 100 90 19 76
Black 2 2 2 8
Mixed race 3 3 2 8
Gender
Female 109 98 25 100
Male 2 2 0 0
Qualifications
None 2 2 0 0
GCSE/O levels (equivalent) 19 17 4 16
A levels (or equivalent) 25 23 5 20
Degree or above 60 54 16 64
Prefer not to say 5 5 0 0
Country of residence
England 84 76 17 68
Scotland 16 14 5 20
Wales 9 8 3 12
Northern Ireland 2 2 0 0
Adapted with permission from Sloan et al. [14].
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Negative influences on MH
Isolation
The three inter-personal WEMBS wellbeing measures
(feeling useful, interested in other people, and feeling
close to others) all showed (non-significant, P-values
> 0.1) small reductions during lockdown. Multiple partic-
ipants discussed feeling isolated and depressed from
reduced social interaction, which was especially severe
among those fully following shielding guidance and living
alone:
Dark moods . . . loneliness. Hard living on my own. Very dark days.
(Participant 67, 60–69 years old)
Fear
Many participants estimated their mortality risk from
COVID-19 as very high and expressed great anxiety dur-
ing interviews and in forum conversations. Anxiety was
often discussed as being increased by official corre-
spondence identifying vulnerability ‘in black and white’
or, conversely, through not having received specific or
sufficient information:
I felt afraid and quite panicked, which led to a massive flare, which
lasted 6 weeks.. . . I don’t know if I will ever feel safe again.
(Participant 132, 40–49 years old)
Non-shielders who felt they should have been allo-
cated to the shielding group reported increased fears
around potential exposure:
I really can’t afford to lose my job, but I really am so scared of
dying!!!. . . I’ve already been told by my lovely nurse I have a DNR
[do not resuscitate order] on my record for COVID-19 and I will not
make it through it. This I know myself; I can’t fight. (Forum, 40–
49 years old)
Additional risk factors, such as being from a Black,
Asian and minority ethnic (BAME) group, also increased
anxiety:
Did make me worry more . . . mainly because they still don’t know
for a fact why black people were dying so much . . . very scary and
made me a lot more vigilant in being careful and safe. (Participant
136, 30–39 years old)
Decreased medical support
Fewer than 30% of survey respondents agreed that they
had felt medically supported during the pandemic. Most
reported cancellations of appointments, and some re-
ceived no communications or response to requests for
help from rheumatology departments:
Flaring badly . . . unable to get hold of my rheumatology team to
help me . . . much more depressed than I was before the coronavi-
rus outbreak. This is partly due to isolation from friends and family
but also because I have felt very vulnerable due to my inability to
get the medical support I have needed. (Survey, 40–49 years old)
Positive influences on MH
Less pressure and increased parity
Most WEMBS measures were higher during lockdown
than pre-lockdown, with three significant improvements
using Student’s paired t test: feeling relaxed [mean dif-
ference (MD) 0.279, 95% CI: 0.103, 0.455, P¼ 0.002],
energy to spare (MD 0.198, 95% CI: 0.027, 0.0370,
P¼0.024) and dealing with problems well (MD 0.243,
95% CI: 0.055, 0.432, P¼0.012). Negative impacts on
MH were found to have significantly lower scores (less
impact) during lockdown, as shown in Fig. 1. The largest
changes were in reductions in the impact of being un-
able to be as physically active as desired (MD 0.752,
95% CI 1.01, 0.495. P< 0.001), the impact of fatigue
and pain on lives, and being made to feel lazy (P-values
< 0.001). These findings were explored during inter-
views, with participants surmising that a reduction in
pressure of normal life combined with the rest of society
being restricted in a similar manner reduced the nega-
tive impact on the chronically diseased:
In terms of the parity, so everyone is locked in so . . . we haven’t ob-
viously met up, but then no-one has, so we’re all in the same boat,
so I’m not missing out, which is nice. (Participant 108, 30–39 years
old)
Resilience
The majority of participants felt they had coped better
with lockdown than the general population (66% of sur-
vey participants), explained, in part, as already having
heavily constrained lives pre-pandemic and/or greater
resilience from living with a chronic disease:
We are a group of people who know how to deal with this. More
than most. We are all fighters who know our bodies better than any-
one. (Participant 55, 40–49 years old)
Fig. 1 shows the changes to impacts on mental health
from baseline (pre-lockdown, March 2020) to follow-up
(June 2020).
Theme 2: inconsistency in classification and
communication
Communication of risk group
Although some participants received prompt communi-
cation of their risk group in late March 2020, there were
often reports of long delays, and others reported receiv-
ing no information at all (22%) or conflicting information
(10%). Qualitative analysis indicated that many partici-
pants who felt they should have been classified as CEV
were not. Fig. 2 contains additional data on the varied
reactions to shielding classification and text communica-
tions. More than 50% of those allocated to the shielding
group agreed that the shielding allocation and communi-
cations had made them feel supported by the govern-
ment and cared about by clinicians. However, 73.4% of
shielders also agreed/strongly agreed that CEV classifi-
cation and communications had increased worries about
health:
It made me feel like they actually knew I had serious health condi-
tions and that they cared. [yet also] . . . worried as it kind of makes
you realize how vulnerable you really are and how dangerous.. . .
(Participant 136, 30–39 years old)









niversity of East Anglia user on 12 April 2021
FIG. 1 Changes to impacts on mental health from baseline (pre-lockdown, March 2020) to follow-up (June 2020)
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FIG. 2 Reactions to allocation of risk group and views on government/National Health Service texts









niversity of East Anglia user on 12 April 2021
A similar percentage (73.0%) reported feeling more
worried about their health as a result of not being allo-
cated to shielding. Interviews identified that they felt at
greater risk, but without individual support or guidance
in managing that risk. There was a statistically significant
difference (Fisher’s exact test, P¼ 0.016) in the propor-
tion of non-shielders (55.8%) who felt ‘abandoned’ due
to their risk grouping and subsequent communications
compared with shielders (25.5%):
I haven’t felt supported by the government at all, either individually
or as a key worker.. . . As a high-risk group, I feel we were a forgot-
ten grey area. (Participant 10, 60–69 years old)
Ongoing communication: keeping informed and
supported
Following the shielding classification, shielded partici-
pants received communications offering advice and sup-
port from a variety of sources, including clinicians, local
council officials, volunteers, NHS and/or government.
However, the quality and quantity of communication and
support received varied. The majority of interviewees ap-
preciated both the information and ‘not being forgotten’:
They [volunteer] cared . . . called me at least four times.. . . They
were really helpful, and I felt like the person I was talking to genu-
inely cares and gave me all the information that was available . . .
the ’phone calls really made a difference. (Participant 136, 30–
39 years old)
More than 50% found individual government/NHS text
messages supportive and a source of helpful informa-
tion, although a minority felt they were too impersonal or
uninformative. However, government briefings were
widely criticized owing to a lack of shielding information:
I feel that as a group, shielders have been ignored in general during
the 3 months of lockdown and have not really been involved in any
of the discussions about shielding. (Forum, 60–69 years old)
Pandemic communications received as part of UK
general population
Central government’s decisions and communications
were generally considered by participants to be incon-
sistent and indecisive, leading to widespread distrust.
Opinions on communications from the devolved govern-
ments, especially Scotland, were generally positive in
terms of perceptions of clarity and transparency. The
frequent government reports highlighting that mortality
was largely among those with ‘underlying health condi-
tions’ was found to exacerbate social and medical inse-
curity in some:
I think it began with [Prime Minister’s] assertion that only the elderly
and those with underlying conditions would be adversely
affected.. . . By stating this, over and over again, he minimized this
part of society. A huge group of people who, from the very top,
didn’t really matter; it was ‘only’ them, almost expendable.
(Participant 29, 40–49 years old)
Table 2 contains further quotations on positive and
negative communication experiences.
Theme 3: the impact of the risk classification and
shielding on multiple domains (identity, society,
support and behavioural)
Being classified (or not) as CEV had wide-ranging
effects on multiple domains of participants lives.
Identity
For many participants, the shielding classification pro-
vided medical and societal acknowledgement, and vali-
dation of the severity of their disease. However, the
term ‘clinically extremely vulnerable’ was sometimes
reported to have negative impacts on social and self-
identity:
I had lupus, but it didn’t stop me working, running, living my life.
Then lockdown happened, and I got all the shielding texts basically
saying don’t go out or you’ll die.. . . It feels like my whole identity
and life has been pulled from underneath me, that I’m now a differ-
ent person, an ill person, worse, whose illness impacts on those I
love. (Forum, 40–49 years old)
Conversely, many of those who did not receive the
shielding classification, yet felt they met the criteria,
expressed feelings of abandonment. For many, this was
experienced as a further extension of the invalidation
faced when struggling to obtain a diagnosis, under-
standing, support and care:
Nobody’s contacted me, nobody’s told me to shield.. . . I feel
neglected.. . . I asked the receptionist, “Can I ask why I haven’t had
a shielding letter?”, and she said, “Well, it’s only sick people that
have the letter”, and I said, “So you don’t consider me sick?”, and
she said, “Well, you haven’t got cancer, have you?” (Participant 28,
50–59 years old)
Society: inclusion vs social stigma
Participants generally reported greater local social inclu-
sion and support during shielding/lockdown than pre-
pandemic. There was a feeling of solidarity from the
whole population being ‘in the same boat’ as the chroni-
cally diseased in their restricted lifestyles, and recogni-
tion of the seriousness of their diseases. However, there
were sometimes also perceptions of social stigma, par-
ticularly feeling ‘blamed’ that lockdown restrictions for
the whole population were to protect only the vulnerable:
It makes you feel like you’re a burden on society, . . . message that
has been sent out by the government, that we’ve all gone into lock-
down to help shielded and the old people.. . . We’re made to feel
othered, we are something else . . . incredibly isolating. (Participant
10, 60–69 years old)
Support with employers and provisions
The shielding classification led to support for working
from home and obtaining provisions. The measures
were generally very well received, although one shielder
felt her employer’s insistence she work from home ow-
ing to her classification was discriminatory.
The negative impact of not receiving a shielding clas-
sification was often considerable, particularly for key-
workers expected to work in high-risk health-care/
school environments, despite feeling at very high risk
from COVID-19:
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I really felt it [classification] was unfair.. . . I’ve never felt as scared to
be potentially going into that [work] situation.. . . I was in tears a lot
. . . panic-type symptoms . . . felt like I was alone.. . . It’s just been
such a trauma, and the lupus has been so bad from the stress.
(Participant 47, 50–59 years old)
Table 3 contains further views of the impact of shield-
ing on identity, society and support.
Behavioural
Risk classification and communications were reported
(Fig. 2) by 84% of shielders (strongly agree/agree) to have
changed their behaviour in terms of social mixing, com-
pared with 52% of non-shielders (Fisher’s exact test on all
five categories, P< 0.001). Discussions during interviews
revealed that many participants were also balancing the
risks and benefits themselves, with leaving the house for
socially distant exercise being felt to be particularly impor-
tant for their MH (Fig. 3). However, more non-shielders
(62%) reported leaving the house for exercise as opposed
to 36% of shielders (v2 test, P¼ 0.006).
Many non-shielders decided to shield, and 71% of
those not allocated to the CEV group agreed that they
had made up their own minds regarding risk decisions,
with the majority assessing themselves as higher risk
than allocated:
I’m taking no chances. I haven’t gone through all those years just to
let some virus kill me because some Doc decides I don’t score
enough points. (Forum, 60–69 years old)
Distrust in government was discussed as reducing ad-
herence to guidance, particularly in relationship to
the planned relaxing of shielding/lockdown. Most partici-
pants felt this was politically/economically motivated and
stated they would make their own decisions, usually in-
volving maintenance of greater socially avoidant
behaviour:
Even if the government say things are alright, I’m going to do what’s
right for me . . . because they’ve not been truthful. (Participant 75,
40–49 years old)
TABLE 2 Communication experiences
Type of communication Positive communication experiences Negative communication
experiences
Communication with individuals Appreciation of regular communica-
tion by multiple methods
It was really good, because they [local
council] also ’phoned and there was a
helpline if you needed anything, and
they’d ’phone every now and again to
check you were OK.. . . It was just
knowing it was there and if I did need
it, it was just a phonecall away.. . .
You get your letters as well, so you’re
always being reminded that there’s
something there. (Participant 66, 40–
49 years old)
Disorganization and delays of initial
shielding communication
I wasn’t told until the beginning of May
that I was high risk from the virus.. . . I
knew they were getting letters and I
thought, where’s my letter? . . . I
thought, well maybe I’m not; maybe
they’ve reviewed me and I’m not high
risk, but it was odd, so I was shielding
anyway . . . confusing . . . disor-
ganized.. . . I really could have done
with their help at the very beginning.
(Participant 12, 40–49 years old)
Ongoing communication: keeping in-
formed and supported
Support and information from LUPUS
UK
If it hadn’t been for updates from
LUPUS UK and my local [LUPUS UK]
branch, it would have been awful.. . .
It was extremely reassuring, like five-
star reassuring, and to know that the
helpline was there if I needed it, just
there, that security was very reassur-
ing. (Participant 22, 60–69 years old)
Lack of government communication
To be mentioned in briefing once every
3 months when you are the part of so-
ciety most impacted by this and
whose lives have changed the most
is poor. Even if they had nothing else
to say, no new information, any sort
of acknowledgement that we exist
would have been welcomed.
(Participant 29, 40–49 years old)
Pandemic communication as part of
UK general population
Confidence owing to perceived
consistency
Nicola Sturgeon . . .she’s been there ev-
ery day throughout the whole pan-
demic, and that’s given me a real
confidence.. . . She takes questions
and she properly answers them;
she’s just brilliant. I really feel we’ve
had very good, concise and clear
messages. (Participant 47, 50–
59 years old)
Perception of indecisiveness and in-
consistency of government
guidance
Because there’s been so much to-ing
and fro-ing with decisions, so are we
wearing masks or not, are we in lock-
down or not lockdown, there was just
not really this is what we’re doing and
here are the reasons, and we’re all
going to stick to it. It was a bit wishy-
washy, I think, [so] not all that confi-
dent really, so I guess that you’re go-
ing to have to look after yourself and
make the decisions for yourself.
(Participant 108, 30–39 years old)
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Theme 4: lessons from lockdown lifestyle for SARD
management
In addition to the improvements in MH shown in Fig. 1,
self-reported fatigue, pain and overall health scores all
improved from pre-lockdown to during lockdown, with
overall health (out of 100) improving from 46.67 to 50.59
(3.92, 95% CI: 0.24, 7.60, P¼ 0.030). This was explored
in interviews, with some participants feeling that pacing
was easier and less guilt inducing owing to more home-
based and/or online work and social lives:
I don’t need to physically return to work . . . offer to Zoom.. . .
People now get that as a viable alternative, so that’s a good out-
come for me. (Participant 105, 50–59 years old)
Many participants discussed improvements in their
health owing to the reduced pressure, both from
TABLE 3 Patient views on impact of shielding/not shielding on identity and the social and practical impact
Identity Discordance in self vs official view of risk and dislike of disease being publicly
known
It’s scary to see it in black and white that we are extremely vulnerable and high risk.
I’ve had lupus for 30 years, and I’ve never considered myself to be sick and vul-
nerable, so receiving the letters and texts is quite difficult to deal with.. . . In addi-
tion, I feel cross that my condition has now been exposed to everyone. (Forum,
50–59 years old)
Dislike of the term ‘vulnerable’ and increased fear owing to strongly worded
risk messaging
I don’t have any help with anything, and to then be told I’m extremely vulnerable and
actually at risk of this and there’s the likelihood that I’ll die if I catch this, it’s just
scary.. . . I hate that [vulnerable] term, it’s a terrible way to put it . . . so they use
such strong words because they want people to take it in and it to resonate with
people. (Participant 80, 20–29 years old)
Social Increased understanding of severity of disease
I think when you have a chronic illness that isn’t visible you can be regarded as a
hypochondriac.. . . If I was permanently in a wheelchair, most people would realize
there is a serious problem.. . . The fact that I had to shield really brought it home to
most of my family and friends. Nearly everyone telephoned to check on me. I had
messages on our village Facebook page offering help. (Participant 124, 70–
79 years old)
Blamed for lockdown, ‘cast aside’ by wider society
According to a large proportion of people, lockdown was introduced because of us
. . . a constant refrain of, ‘keep the vulnerable, that word again, inside and let us
get on with our lives.’ This has made me so, so incredibly sad. I’ve worked hard
to make sure I contribute to society.. . . Now I’m cast aside, seen as someone that
needs to be locked away so as not to inconvenience everyone else. I find it hurtful
that so many people see that as a logical and acceptable solution. It really upsets
me. (Participant 29, 40–49 years old)
Increased local community cohesion
She [daughter] said she’s going to remember lockdown as the year her neighbours
became her family. It was such a small thing, but the impact was huge. We all felt
the community spirit. (Forum, 40–49 years old)
Support: employment and provisions Difficulties and stress for those not meeting shielding criteria to obtain evi-
dence for employers
I think whatever criteria the government set out for these letters somehow skipped
over SLE as an extremely complicated autoimmune disease itself.. . . GP really
wanted me to ‘shield’ for the 12 weeks as I’m very at risk, but because the criteria
didn’t match she couldn’t give me the letter. Obviously, everyone knows to use
their common sense and isolate at this time, but I needed this letter for work and
really had to fight for it. (Forum, 40–49 years old)
Practical support for shopping, medications and evidence for employers
appreciated
I think I probably got more support as it shows how serious and dangerous my situa-
tion is . . . priority slots for my shopping to be delivered . . . medication delivered
. . . got the free food boxes delivered from the government.. . . I don’t need to
physically return to work. It now feels a lot easier. (Participant 136, 30–39 years
old)
Disparate views on quality of government-provided food boxes
The food parcels were excellent considering what they had to do quickly and for the
numbers needed. (Survey, 40–49 years old)
The cheapest stuff.. . . And that again that message from the government is, is that’s
what you’re worth, we can furlough people at 80% of their salary, I’m not knock-
ing that, we can pay for this and that, and we can give you all a Nando’s voucher
now, but you shielding people are just worth the world’s worst toilet roll and an
onion the size of your head. (Participant 10, 60–69 years old)
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themselves and from society, to maintain a normal life
during lockdown:
I am in a much better place both mentally and physically than be-
fore lockdown.. . . I have been able to focus on me.. . . If I don’t feel
like doing something . . . no guilt, shame, embarrassment.
(Participant 111, 20–29 years old)
However, other participants reported increased symp-
toms and flares of disease activity. The importance of
outdoor exercise was also regularly highlighted, and
several considered that their health had worsened with-
out the routine or purpose of work/socializing/exercising
outside the home:
My mobility has been hugely affected . . . very frustrated, angry and
emotional . . . managed my disease better when I was leaving the
house; it gave me some purpose. Staying at home has left me alone
with my pain. (Participant 132, 40–49 years old)
Discussion
The principle of shielding was very well supported by
the lupus and related SARD patients in this study. Many
perceived it as a beneficent act of protection and care,
providing information and practical support, and valida-
tion of the seriousness of their disease. However, the
FIG. 3 The range of behavioural choices made by participants
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term ‘vulnerable’ was widely disliked. Some participants
felt that being labelled ‘vulnerable’ subsumed all their
other identities, exposed their disease status more
widely than preferred and/or classed them as a separate
(sometimes perceived as of lesser value) entity to the
‘normal’ population. This sense of being ‘othered’ [22]
was reported by participants to have been exacerbated
by government briefings often failing to inform or ac-
knowledge the CEV group; providing reassurance to the
general public that most deaths were among those with
underlying health conditions [23]; and/or reports of the
de-prioritization of people with such conditions in inten-
sive care units [24]. This highlights the importance of
communication strategies encouraging social cohesion
and avoiding the implicit or accidental stigmatizing of
any ‘vulnerable’ group.
Although strongly worded messaging about COVID-19
risk engendered more socially avoidant behaviours, it also
greatly increased anxiety, which was reported by some to
have precipitated disease flares. Fears were compounded
by widespread distrust in central government, with percep-
tions of inconsistent messaging (although the devolved
governments’ pandemic communications were generally
viewed favourably) and rapidly changing guidance, as
reported in other studies [25]. Although generating anxiety
can ensure higher compliance with safety measures in pan-
demics [26], we agree with a recent call for encouraging
adherence to behavioural guidance while also promoting
wellbeing and ‘minimizing distress’ [27]. This might be
helped by more personalized risk assessments and more
frequent, less negatively framed messaging. Many partici-
pants perceived their mortality risk from COVID-19 as very
high, when evolving understanding (rarely communicated to
patients) was that it was much less than initially assumed
and only marginally raised for most SARD patients [28, 29].
Although a recent study found a (slightly) increased all-
cause mortality rate in March–April 2020 for patients with
SARDs and similar diseases compared with the general
population [30], it has not yet been ascertained how much
of this increase was directly from COVID-19 or from the se-
vere reduction and delays in medical care for lupus/SARDs,
as reported in our previous study [14] and others [31].
Absent, delayed or miscommunication regarding
shielding was identified in our research and other
reports [32], and caused additional distress and anxiety.
Although personalized contact was most appreciated,
the largely positive views of generic NHS/government
texts (examples in Supplementary Data S2, available at
Rheumatology Advances in Practice online) suggest that
these types of communication can be a cost-effective
means of showing support and influencing behaviour
(consistent with findings for other patient groups [33])
and could be developed further for post-pandemic
times. Both non-shielders and shielders who perceived
a lack of communication/support from clinicians or gov-
ernment used terminology suggestive of an overall feel-
ing of abandonment, as found in other studies including
SARDs patients [14, 15]. Feelings of abandonment were
highest in non-shielders, who often felt that they should
have been allocated to the shielding group. A study of
patients with IBD also found a discordance between
self-assessment and official COVID risk assessment, es-
pecially regarding immunosuppression [34].
Caution is required in research comparing officially al-
located shielding/non-shielding groups (e.g. Kipps et al.
[35]), because we found that shielding allocation did not
lead to two distinct groups, owing to participants often
making their own decisions. Although socially distant be-
haviour was reported to be greater in the government-
allocated shielded group, most participants also bal-
anced the risks and benefits themselves, particularly in
terms of the improvements to MH from leaving the house
for socially distant exercise [36]. The reduction in mobility
and fitness reported by some shielding participants ow-
ing to confinement to the house was also found in studies
of patients shielding because of other diseases [37].
Many non-shielders independently attempted to follow
the shielding guidance, but were sometimes unable to do
so without support with employment or provisions. This
caused great stress and potentially increased risk of
COVID-19, especially among some keyworkers who were
expected to continue working. Being omitted from shield-
ing classification/communication often reinforced medi-
cal insecurity, invalidation and the perception of lupus
and related SARDs being widely misunderstood, gener-
ated from previous dismissive responses and misdiagno-
ses common in this patient group [12, 38, 39].
Overall wellbeing as measured by the WEMBS (<40
at both time points) places this cohort in the bottom
15% of UK population samples for wellbeing [17] and
points to the requirement for more wellbeing support for
SARD patients regardless of the additional pandemic
challenges. There was an unexpected slight improve-
ment (non-significant) between pre-lockdown WEMBS
scores in early March 2020 and June 2020, and statisti-
cally significant improvements to multiple other health
and wellbeing measures, including reductions in guilt,
feeling a burden, and the impact of fatigue and pain on
lives. Although not negating the need for urgent MH
support for those most adversely impacted by the pan-
demic, this does raise questions regarding why this im-
provement might have occurred. Patients and the
research team speculate that it might be attributable to
the lockdown creating reduced pressure and greater op-
portunity to rest and pace activities without guilt or fear of
societal or self-censure for being unable to participate fully
in life. SARD patients might also have had greater resil-
ience to potential adverse impacts on MH from lockdown/
shielding as a result of having pre-adapted to a physically
and socially constrained lifestyle and having more devel-
oped coping strategies than the general population.
However, some situations that led to improvements are
clearly not replicable in non-pandemic times, such as the
reported reductions of sadness in missing out on ‘normal’
life owing to the general population being in lockdown.
Limitations of this study include the fact that diagnoses
were self-reported. The very few male participants and
an under-representation of some ethnic groups, as is
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common in research in this patient group [40], reduce the
generalizabilty. Purposive sampling allowed for a more
representative balance of ethnic groups for interviews,
and other socio-demographic groups were well repre-
sented in both surveys and interviews. All participants
were initially recruited through online support groups, and
group members might differ in their experiences and
behaviours compared with the wider lupus and SARD
population. It is important to note that the findings of this
study are from only the early stage of the pandemic, and
views and wellbeing might well change as the pandemic
progresses. Strengths include increased validation from
triangulation from multiple data sources, member check-
ing [20] and anomalous case analyses [21].
In conclusion, there was a widespread fear of dying
from COVID-19 and a high level of support for social
distancing measures, including shielding. Classification
and communications were perceived as inconsistent,
and many SARD patients who felt that they were at high
risk from COVID-19 were not advised that they should
shield. Although fear, isolation and the reduction in med-
ical care were reported to have impacted physical and
mental health negatively, some improvements occurred,
probably attributable to a reduced pace of life during
lockdown. This highlights the importance of clinicians
advising on modifications to busy pre-disease lifestyles,
self-management with pacing strategies and flexible
working for many with chronic diseases where fatigue is
a major life-changing symptom.
At the time of writing, ‘long COVID’ clinics are being
established for those experiencing ongoing symptoms,
including fatigue, cognitive dysfunction and pain. We
strongly advocate for this type of support to be extended
to patients with SARDs and other chronic diseases with
similar debilitating symptoms that are often experienced
for many years, with limited/no support to date.
Supplementary data
Supplementary data are available at Rheumatology
Advances in Practice online.
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